Clinical Trial

The Impact of Rhinoplasty Approach and Used Autologous Cartilage Grafts on the Nasal Skin-soft Tissue Envelope Metabolism

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2024 (before its estimated January 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective observation cohort investigation. Patients, that is participants, undergoing primary functional rhinoplasty will be evaluated in terms of measuring capillary blood lactic acid concentration in the nasal skin-soft tissue envelope immediately after the procedure and 7 days after the procedure. The aim of our study is to test whether or not different rhinoplasty approaches and volume of the used autologous cartilage grafts impact the nasal skin-soft tissue metabolism.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-22.
Trial Details
NCT Number NCT06384469
Lead Sponsor University Hospital Sestre Milosrdnice
Conditions Rhinoplasty, Nasal Skin-soft Tissue Envelope Metabolism, Lactic Acid, Autologous Cartilage Grafting
Enrollment 100 participants
Start Date 2025-01-02
Primary Completion 2026-01-02 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-29